The resulting compound <b>10</b> combined high and specific PSMA-binding affinity (IC<sub>50</sub> = 4.39 ± 1.69 nM) and good uptake in tumor cells and tumor xenografts with extremely low off-target tissue retention. Here, FOLH1 is linked to neoplasm.